Skip to Main Content

Author Details

Andrew M Evens
Rutgers Robert Wood Johnson Medical School
1998
219
56
PMIDPaper TitleJournal TitlePublished Year
35904727COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivors.J Cancer Surviv2024
36083129Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.Blood Adv2023
37729621Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.Blood Adv2023
37603594Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.Blood Adv2023
37259563An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy.Blood Adv2023
36947720Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography-Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study.JCO Oncol Pract2023
37452275Factors associated with health-related quality of life in a cohort of cancer survivors in New Jersey.BMC Cancer2023
37242237Sociodemographic and Health Correlates of Multiple Health Behavior Adherence among Cancer Survivors: A Latent Class Analysis.Nutrients2023
37129856Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.Br J Haematol2023
36965007Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.Am J Hematol2023
36960939EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.Leuk Lymphoma2023
36495588The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.J Clin Oncol2023
34162178Older patients (aged â¿¥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.Haematologica2022
35830649Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.N Engl J Med2022
35491747End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma.Br J Haematol2022
36359241An Analysis of Transcriptomic Burden Identifies Biological Progression Roadmaps for Hematological Malignancies and Solid Tumors.Biomedicines2022
36224623Scaffold-mediated switching of lymphoma metabolism in culture.Cancer Metab2022
36055310CNS prophylaxis for diffuse large B-cell lymphoma.Lancet Oncol2022
35227310Successful administration of chimeric antigen receptor (CAR) T-cell therapy in patients requiring hemodialysis.Exp Hematol Oncol2022
35254922Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine Shortage.JCO Oncol Pract2022
35285979Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma.Am J Hematol2022
34886751Treatment patterns for relapsed and refractory Hodgkin lymphoma in a community oncology setting.Leuk Lymphoma2022
35093285Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.Clin Lymphoma Myeloma Leuk2022
35166393Survivorship transition care experiences and preparedness for survivorship among a diverse population of cancer survivors in New Jersey.Eur J Cancer Care (Engl)2022
34525177Defining and treating high-grade B-cell lymphoma, NOS.Blood2022
34848181Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.Clin Lymphoma Myeloma Leuk2022
34794912Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.Clin Lymphoma Myeloma Leuk2022
32992341Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma.Blood2021
33599303SARS-CoV-2 nosocomial infection: Real-world results of environmental surface testing from a large tertiary cancer center.Cancer2021
33538152Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.Haematologica2021
33843922Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.Clin Adv Hematol Oncol2021
33502927Burkitt Lymphoma International Prognostic Index.J Clin Oncol2021
34765544Oncogenic Integration of Nucleotide Metabolism <i>via</i> Fatty Acid Synthase in Non-Hodgkin Lymphoma.Front Oncol2021
34673965Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma.JAMA Netw Open2021
34448831Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma.Blood Adv2021
34504223Socioeconomic inequalities in treatment and relative survival among patients with diffuse large B-cell lymphoma: a Hong Kong population-based study.Sci Rep2021
34338127A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBVâ¿¿+â¿¿lymphomas.Leuk Lymphoma2021
34283175HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.Blood Adv2021
34330667Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapy.J Geriatr Oncol2021
32663292Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.Blood2021
31452195Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma.Br J Haematol2020
32090325First-line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare population-based study.Br J Haematol2020
32102579A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphoma.Leuk Lymphoma2020
31772298Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma.Leukemia2020
33030980Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.J Clin Oncol2020
32804274Lymphoma Occurring During Pregnancy: Current Diagnostic and Therapeutic Approaches.Curr Oncol Rep2020
32328822Current Treatment Options for Older Patients with Hodgkin Lymphoma.Curr Treat Options Oncol2020
32532790A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408.Clin Cancer Res2020
32452714Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816.Leuk Lymphoma2020
32557589How I treat advanced Hodgkin lymphoma - a global view.Br J Haematol2020
  • 1 - 50 of 219

Recommended Authors

Felipe Batalini
Mayo Clinic Arizona
Career Start Year 2015
Number of shared co-authors 1
Srinivas K Tantravahi
Huntsman Cancer Institute at the University of Utah.
Career Start Year 2012
Number of shared co-authors 1
Xiaoqiong Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 1
Gareth P Gregory
School of Clinical Sciences at Monash Health, Monash University
Career Start Year 2011
Number of shared co-authors 0
David Wu
University of Washington
Career Start Year 2010
Number of shared co-authors 3
Melissa C Larson
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 3
Sameer A Parikh
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 3
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Career Start Year 2009
Number of shared co-authors 2
Prapti Patel
The University of Texas Southwestern Medical Center
Career Start Year 2009
Number of shared co-authors 5
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Milos D Miljkovic
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2009
Number of shared co-authors 3
Kara L Davis
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Amanda Winters
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Geoffrey Shouse
City of Hope National Medical Center
Career Start Year 2007
Number of shared co-authors 2
Aarthi Shenoy
MedStar Washington Hospital Center
Career Start Year 2006
Number of shared co-authors 1
Marlise R Luskin
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 5
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 3
Ronan Swords
Oregon Health and Science University
Career Start Year 2004
Number of shared co-authors 6
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 4
Sze Fai Yip
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 1
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 4
Changchun Deng
Center for Lymphoid Malignancies, Columbia University Medical Center
Career Start Year 1997
Number of shared co-authors 0
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 5
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 1984
Number of shared co-authors 12
Richard T Maziarz
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 7
Sherrie L Perkins
University of Utah
Career Start Year 1982
Number of shared co-authors 2
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Career Start Year 1981
Number of shared co-authors 8
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 8
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 0
Robin Fo??
Sapienza University.
Career Start Year 1968
Number of shared co-authors 5

Collaborators

Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Co-authored papers 22
Afshin Beheshti
Co-authored papers 15
Charles L Bennett
University of South Carolina
Co-authored papers 14
Steven M Trifilio
Northwestern Memorial Hospital
Co-authored papers 12
Steven T Rosen
Co-authored papers 12
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Co-authored papers 11
June M McKoy
Feinberg School of Medicine, Northwestern University
Co-authored papers 10
Dennis W Raisch
The University of New Mexico
Co-authored papers 9
Timothy M Kuzel
548377Rush University Medical Center
Co-authored papers 6
John Tyson McDonald
Co-authored papers 6
Steven M Belknap
Northwestern University Feinberg School of MedicineChicago
Co-authored papers 5
Paul R Yarnold
University of South Carolina College of Pharmacy
Co-authored papers 5
Dennis P West
Feinberg School of Medicine, Northwestern University
Co-authored papers 4
Elisa V Bandera
Co-authored papers 4
Alexey V Danilov
City of Hope National Medical Center
Co-authored papers 4
Shawn Levy
HudsonAlpha Institute for Biotechnology
Co-authored papers 4
Shawna V Hudson
Rutgers Robert Wood Johnson Medical School
Co-authored papers 4
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Briseis Aschebrook-Kilfoy
University of Chicago
Co-authored papers 4
Cara Angelotta
Northwestern University, Feinberg School of Medicine
Co-authored papers 4
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Kikkeri N Naresh
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Charles R Vanderburg
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 3
David A Rizzieri
Duke University Medical Center
Co-authored papers 3
Cara C Tigue
McMaster University.
Co-authored papers 2
Lifang Hou
Co-authored papers 2
Robin Ruthazer
Tufts Clinical and Translational Science Institute, 7Tufts Medical Center
Co-authored papers 2
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Bijal Shah
Moffitt Cancer Center
Co-authored papers 2
Fr??d??ric Amant
Netherlands Cancer Institute
Co-authored papers 2
Release 1.2